Multiplicity of α-Synuclein Aggregated Species and Their Possible Roles in Disease
α-Synuclein amyloid aggregation is a defining molecular feature of Parkinson’s disease, Lewy body dementia, and multiple system atrophy, but can also be found in other neurodegenerative disorders such as Alzheimer’s disease. The process of α-synuclein aggregation can be initiated through alternative...
Main Authors: | Pablo Gracia, José D. Camino, Laura Volpicelli-Daley, Nunilo Cremades |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8043 |
Similar Items
-
Initiation and propagation of α-synuclein aggregation in the nervous system
by: Baraa A. Hijaz, et al.
Published: (2020-03-01) -
Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
by: Hazel L. Roberts, et al.
Published: (2015-03-01) -
The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases
by: Nunilo Cremades, et al.
Published: (2018-01-01) -
One ring is sufficient to inhibit α-synuclein aggregation
by: Samuel Pena-Díaz, et al.
Published: (2022-01-01) -
Toxic species in amyloid disorders: Oligomers or mature fibrils
by: Meenakshi Verma, et al.
Published: (2015-01-01)